Last updated on March 2020

OPsumit USers Registry

Brief description of study

Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) and to describe clinical characteristics and outcomes of patients newly treated with Opsumit in the post-marketing setting.

Clinical Study Identifier: NCT02126943

Find a site near you

Start Over

investigator Site

San Juan, Puerto Rico
  Connect »

Investigator Site

Guaynabo, Puerto Rico
  Connect »